Mark W Russo1, Michael W Fried. Show Affiliations » 1. Division of Digestive Diseases, University of North Carolina at Chapel Hill, 27599, USA.
Abstract
Entities: Disease
Mesh: See more » Antiviral Agents/administration & dosageAntiviral Agents/adverse effectsDrug Therapy, CombinationHematologic Diseases/chemically inducedHepatitis C, Chronic/drug therapyHumansInterferon alpha-2Interferon-alpha/administration & dosageInterferon-alpha/adverse effectsLung Diseases/chemically inducedMental Disorders/chemically inducedNervous System Diseases/chemically inducedPolyethylene Glycols/administration & dosagePolyethylene Glycols/adverse effectsRecombinant ProteinsRibavirin/administration & dosageRibavirin/adverse effectsThyroid Diseases/chemically induced
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2bpeginterferon alfa-2a
Year: 2003 PMID: 12761728 DOI: 10.1016/s0016-5085(03)00394-9
Source DB: PubMed Journal: Gastroenterology ISSN: 0016-5085 Impact factor: 22.682